First Patient Enrolled in New Study Assessing early prediction of flares in Atopic Dermatitis by Castle Biosciences in Collaboration with SciBase

Contributed by: PR Newswire

Tags

SCIBASE-DETECT-AD

More Like This

SciBase receives initial order for clinical study from Castle Biosciences

SciBase announces collaboration for prediction of atopic dermatitis in infants

SciBase has signed a Collaboration and License Agreement with Castle Biosciences to develop diagnostic tests within dermatology and intends to carry out a directed share issue of approximately MSEK 30

SciBase Announces Positive Findings in Case Study Monitoring Treatment Outcomes in Atopic Dermatitis Patient

A new study demonstrates that Nevisense can predict atopic dermatitis in Newborns

Study that highlights Nevisense potential for prediction of AD published in leading journal

Nevisense detects skin barrier dysfunction in children with Atopic Dermatitis

SciBase and Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million